| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/17/2013 | CN102512524B Medicine for treating secretory otitis media and acute suppurative otitis media |
| 07/17/2013 | CN102210864B Formula of medicament for treating non-infectious ocular inflammations, and inhibiting corneal neovascularization and anti-rejection reaction generated after corneal transplantation |
| 07/17/2013 | CN102083434B Aqueous liquid containing gatifloxacin |
| 07/17/2013 | CN101698026B Method for producing traditional Chinese medicine formula for treating eye disease of amblyopia |
| 07/16/2013 | US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 07/16/2013 | US8486954 Heterobicyclic carboxamides as inhibitors for kinases |
| 07/16/2013 | US8486923 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 07/16/2013 | US8486464 Herbal composition for angina pectoris, method to prepare same and uses thereof |
| 07/16/2013 | CA2754589C Steroid compound |
| 07/16/2013 | CA2707067C Clear ophthalmic solution comprising latanoprost as active ingredient |
| 07/16/2013 | CA2490542C Fas peptide mimetics and uses thereof |
| 07/16/2013 | CA2477283C Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes |
| 07/11/2013 | WO2013103632A1 Double-stranded rna compounds to casp2 and uses thereof |
| 07/11/2013 | WO2013102907A1 Ophthalmic composition |
| 07/11/2013 | WO2013065015A3 Butea monosperma and curcuma longa extracts for the prevention and treatment diabetic retinopathy and cataract |
| 07/11/2013 | WO2013051904A9 Composition for preventing and treating vision deterioration and age-related macular degeneration through retinal repair using ginseng/red ginseng extracts and ginsenoside |
| 07/11/2013 | WO2013046059A3 Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose |
| 07/11/2013 | WO2012061045A3 Methods and compositions for preserving retinal ganglion cells |
| 07/11/2013 | US20130178524 Prostaglandin-containing product |
| 07/11/2013 | US20130177647 Methods for manipulating satiety |
| 07/11/2013 | US20130177599 Methods and kits for extending contact lens use |
| 07/10/2013 | EP2612664A1 Stabilized polyphenol solution and method for stabilizing polyphenol solution |
| 07/10/2013 | EP2611918A1 Mirnas involved in the blood brain barrier function |
| 07/10/2013 | EP2611502A1 Adenosine a3 receptor modulating compounds and methods of use thereof |
| 07/10/2013 | EP2611415A1 Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension |
| 07/10/2013 | CN1990473B Tri-substituted 1H-imidazoles compounds, preparation method and pharmaceutical composition and pharmacy use thereof |
| 07/10/2013 | CN103201280A Compositions and methods for inhibition of the jak pathway |
| 07/10/2013 | CN103200952A Treatment of diseases |
| 07/10/2013 | CN103200942A Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol |
| 07/10/2013 | CN103200941A Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure |
| 07/10/2013 | CN103193773A Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of diseases |
| 07/10/2013 | CN103191411A Cyclosporine a and amphiphilic hyaluronic acid derivative composition and preparation method thereof |
| 07/10/2013 | CN103191397A Medicament for treating xerophthalmia of information staff in hospitals |
| 07/10/2013 | CN103191387A Medicament for treating juvenile myopia |
| 07/10/2013 | CN103191314A Chinese medicinal composition for treating Menieres syndrome |
| 07/10/2013 | CN103191230A Traditional Chinese medicine for treating infantile recurrent hordeolum |
| 07/10/2013 | CN103191215A Eye drops for treating conjunctivitis |
| 07/10/2013 | CN103191213A Traditional Chinese medicine for treating otitis media |
| 07/10/2013 | CN103191129A Oxylipin compositions for the treatment of ophthalmic conditions |
| 07/10/2013 | CN103191119A Use of itraconazole in inhibiting of Akt kinase (protein kinase B) activity |
| 07/10/2013 | CN103190569A Traditional Chinese medicine health-care food for effectively treating meniere disease |
| 07/10/2013 | CN102641431B Medicament for treating vitreous opacity |
| 07/10/2013 | CN102526462B Traditional Chinese medicine composition for treating tinnitus |
| 07/10/2013 | CN102512362B Formula and preparation method of compound ciprofloxacin eye drops |
| 07/10/2013 | CN102370830B Eyesight-improving massage Chinese medicinal preparation and preparation method thereof |
| 07/10/2013 | CN101801391B Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection |
| 07/10/2013 | CN101516385B Treatment of excessive neovascularization |
| 07/10/2013 | CN101253166B Sulfonamide compound |
| 07/10/2013 | CN101107005B CRIg polypeptide for prevention and treatment of complement-associated disorders |
| 07/09/2013 | US8481516 Ciclesonide containing sterile aqueous suspension |
| 07/09/2013 | US8481513 3, 10, and 12a substituted tetracycline compounds |
| 07/09/2013 | US8481091 Pharmaceutical compositions |
| 07/04/2013 | WO2013101926A1 Benzimidazole derivatives as selective blockers of persistent sodium current |
| 07/04/2013 | WO2013101911A2 Benzimidazole derivatives as selective blockers of persistent sodium current |
| 07/04/2013 | WO2013067076A3 Methods and compositions for neuroprotection |
| 07/04/2013 | WO2013055073A3 Ophthalmic composition containing cyclosporine and method for preparing same |
| 07/04/2013 | WO2013038195A3 Pharmaceutical nanoparticle compositions |
| 07/03/2013 | EP2609933A1 Aqueous composition for ophthalmic administration |
| 07/03/2013 | CN103189060A Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 07/03/2013 | CN103189058A Ophthalmic compositions |
| 07/03/2013 | CN103183675A Phosphodiesterase-4 inhibitor |
| 07/03/2013 | CN103183660A Chromane derivative used as TRPV3 (transient receptor potential vanilloid 3) conditioning agent |
| 07/03/2013 | CN103183659A Chromane derivative used as TRPV3 (transient receptor potential vanillin 3) regulator |
| 07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
| 07/03/2013 | CN103182075A Lysozyme preparation, preparation method thereof, and application thereof |
| 07/03/2013 | CN103182074A Ophthalmic preparation containing lysozyme |
| 07/03/2013 | CN103182028A Health care medicine |
| 07/03/2013 | CN103181941A Application of icariin or icarisid II in preparation of medicine for preventing and curing diabetic retinopathy |
| 07/03/2013 | CN103181919A Stable ophthalmic formulations |
| 07/03/2013 | CN103181892A Moxifloxacin hydrochloride eye drops and preparation method thereof |
| 07/03/2013 | CN102631623B Traditional Chinese medicine composite for treating thyroid associated ophthalmopathy and preparation method thereof |
| 07/03/2013 | CN102309669B Chinese medicinal preparation for treating allergic conjunctivitis |
| 07/03/2013 | CN101766643B Dendrobii extract and preparation method thereof |
| 07/03/2013 | CN101665536B Anti-vegf antibodies |
| 07/03/2013 | CN101502648B Vaccine |
| 07/03/2013 | CN101035530B VEGF inhibition |
| 07/02/2013 | CA2742946C Antioxidant |
| 07/02/2013 | CA2560559C Aqueous intraocular penetration-promoting eye drop |
| 07/02/2013 | CA2445729C Use of metals to treat mucosal membranes |
| 07/02/2013 | CA2373178C The use of a protein tyrosine kinase pathway inhibitor in the treatment of ocular disorders |
| 06/27/2013 | WO2013096857A1 Combination anti-inflammatory ophthalmic compositions |
| 06/27/2013 | WO2013096689A1 Anti allergen composition and spray formulation comprising the same |
| 06/27/2013 | WO2013096405A1 Chewing gum products containing [(2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester |
| 06/27/2013 | WO2013091539A1 Pyrrole six-membered heteroaryl ring derivative, preparation method therefor, and medicinal uses thereof |
| 06/27/2013 | WO2013059837A3 Systems and methods for corneal cross-linking with pulsed light |
| 06/27/2013 | US20130165503 Method for Treating Ocular Neovascularization |
| 06/27/2013 | US20130165419 Combination anti-inflammatory ophthalmic compositions |
| 06/27/2013 | US20130164387 Novel mannopyranoside derivatives with anticancer activity |
| 06/27/2013 | CA2857977A1 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof |
| 06/26/2013 | EP2607348A2 Plasminogen Activator Inhibitor-1 Inhibitor |
| 06/26/2013 | EP2606899A1 High viscosity macromolecluar compositions for treating ocular conditions |
| 06/26/2013 | EP2605777A1 Ep2 or ep4 agonists for treating corneal haze |
| 06/26/2013 | CN103180444A Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
| 06/26/2013 | CN103179960A Pharmaceutical combinations for the treatment of metabolic disorders |
| 06/26/2013 | CN103173338A Health care wine |
| 06/26/2013 | CN103172619A 4-(substituted benzyl)-1(2H)-2,3-phthalazinone derivatives, and preparation methods, medicinal compositions and uses thereof |
| 06/26/2013 | CN103172573A Particulates of crth2 antagonist |
| 06/26/2013 | CN103172568A Cathepsin cysteine protease inhibitors |
| 06/26/2013 | CN103169864A Fluid-increasing decoction formula granules and preparation method, application and detection method thereof |
| 06/26/2013 | CN103169819A Pustule cleaning liquid medicine |